| P50 | author | Lies Lahousse | Q30422940 |
| | Guy Brusselle | Q55233371 |
| | Oscar H Franco | Q56839732 |
| P2093 | author name string | Bruno H Stricker | |
| | Guy F Joos | |
| | Leen J M Seys | |
| P2860 | cites work | Influence of N-acetylcysteine on chronic bronchitis or COPD exacerbations: a meta-analysis | Q26795648 |
| | Chronic bronchitis and chronic obstructive pulmonary disease | Q26991702 |
| | The chronic bronchitis phenotype in chronic obstructive pulmonary disease: features and implications | Q28081970 |
| | Prevalence and incidence of COPD in smokers and non-smokers: the Rotterdam Study | Q28387926 |
| | Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper | Q29614960 |
| | Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary | Q29614970 |
| | Characterisation of COPD heterogeneity in the ECLIPSE cohort | Q34149510 |
| | COPD exacerbations: causes, prevention, and treatment | Q34287943 |
| | The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study | Q35201858 |
| | Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease | Q35534824 |
| | Risk factors of readmission to hospital for a COPD exacerbation: a prospective study. | Q35535679 |
| | Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. | Q35537270 |
| | The Rotterdam Study: 2016 objectives and design update | Q36084114 |
| | The phenotype of concurrent chronic bronchitis and frequent exacerbations in patients with severe COPD attending Swedish secondary care units | Q36240664 |
| | Pathophysiology of exacerbations of chronic obstructive pulmonary disease | Q36458964 |
| | The Presence of Chronic Mucus Hypersecretion across Adult Life in Relation to Chronic Obstructive Pulmonary Disease Development | Q36778643 |
| | High-dose oral N-acetylcysteine fails to improve respiratory health status in patients with chronic obstructive pulmonary disease and chronic bronchitis: a randomized, placebo-controlled trial | Q36838747 |
| | Persistent and Newly Developed Chronic Bronchitis Are Associated with Worse Outcomes in Chronic Obstructive Pulmonary Disease | Q37241645 |
| | Infection in the pathogenesis and course of chronic obstructive pulmonary disease | Q37336494 |
| | An official American Thoracic Society/European Respiratory Society statement: research questions in COPD. | Q38398677 |
| | Chronic obstructive pulmonary disease mortality in six U.S. cities | Q39282900 |
| | Patient's perception of exacerbations of COPD--the PERCEIVE study | Q39346777 |
| | Chronic mucus hypersecretion in COPD and death from pulmonary infection | Q40682332 |
| | Treatable traits: toward precision medicine of chronic airway diseases | Q40940115 |
| | Prevalence and characteristics of three clinical phenotypes of chronic obstructive pulmonary disease (COPD). | Q43882168 |
| | Chronic obstructive pulmonary disease in the absence of chronic bronchitis in China | Q44364751 |
| | Cough and sputum production are associated with frequent exacerbations and hospitalizations in COPD subjects. | Q44994420 |
| | Gender difference in smoking effects on lung function and risk of hospitalization for COPD: results from a Danish longitudinal population study. | Q50560558 |
| | Changes in forced expiratory volume in 1 second over time in COPD. | Q51521679 |
| | Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. | Q53577143 |
| | Sex Differences in Chronic Obstructive Pulmonary Disease Mechanisms. | Q53765643 |
| | Effect of roflumilast on exacerbations in patients with severe chronic obstructive pulmonary disease uncontrolled by combination therapy (REACT): a multicentre randomised controlled trial. | Q55058878 |
| | Risk factors for chronic mucus hypersecretion in individuals with and without COPD: influence of smoking and job exposure on CMH | Q57273471 |
| | Sex Differences in Mortality and Clinical Expressions of Patients with Chronic Obstructive Pulmonary Disease | Q57955766 |
| | Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease | Q57955820 |
| | Thirty-year cumulative incidence of chronic bronchitis and COPD in relation to 30-year pulmonary function and 40-year mortality: a follow-up in middle-aged rural men | Q79225774 |
| | The chronic bronchitis phenotype in subjects with and without COPD: the PLATINO study | Q83336665 |
| | Chronic bronchitis in COPD patients is associated with increased risk of exacerbations: a cross-sectional multicentre study | Q86773781 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bronchitis | Q173022 |
| | chronic obstructive pulmonary disease | Q199804 |
| P577 | publication date | 2017-08-10 | |
| P1433 | published in | European Respiratory Journal | Q12257435 |
| P1476 | title | Epidemiology and impact of chronic bronchitis in chronic obstructive pulmonary disease | |
| P478 | volume | 50 | |